A beam phase measuring system for the TRIUMF cyclotron

por Burge, R S, Vader, R
Publicado 1981

THE MEASUREMENT OF MASS, THICKNESS, AND DENSITY IN THE ELECTRON MICROSCOPE

por Burge, R. E., Silvester, N. R.
Publicado 1960

A Quantitative Estimation of the Uptake of Two New Electron Stains by the Cytoplasmic Membrane of Ram Sperm

por Silvester, N. R., Burge, R. E.
Publicado 1959

Precision NMR measurement of the TRIUMF cyclotron magnetic field

por Burge, R S, Dennison, G, Dohan, D A
Publicado 1984

Development of the osteoporosis assessment questionnaire—physical function (OPAQ-PF): an osteoporosis-targeted, patient-reported outcomes (PRO) measure of physical function

por Naegeli, A. N., Nixon, A., Burge, R., Gold, D. T., Silverman, S.
Publicado 2013

Hip and other fragility fracture incidence in real-world teriparatide-treated patients in the United States

por Burge, R. T., Disch, D. P., Gelwicks, S., Zhang, X., Krege, J. H.
Publicado 2016

Examining the treatment gap and risk of subsequent fractures among females with a fragility fracture in the US Medicare population

por Keshishian, A., Boytsov, N., Burge, R., Krohn, K., Lombard, L., Zhang, X., Xie, L., Baser, O.
Publicado 2017

Achievement and control of the 100 $\mu, \Alpha$ beam at TRIUMF

por Blackmore, E W, Bosman, P, Burge, R, Dutto, G, Gill, D, MacKenzie, G H, Schmor, P W
Publicado 1978

Osteoporosis Assessment Questionnaire-Physical Function (OPAQ-PF): a psychometrically validated osteoporosis-targeted patient reported outcome measure of daily activities of physic...

por Nixon, A., Kerr, C., Doll, H., Naegeli, A. N., Shingler, S. L., Breheny, K., Burge, R., Gold, D. T., Silverman, S.
Publicado 2014

Clinical outcomes at 1 year in early Psoriasis Area and Severity Index responders compared with non‐responders: Subgroup analysis of UNCOVER‐3 trial

por Rosmarin, D., Smith, S., Shrom, D., Burge, R., See, K., McKean‐Matthews, M., Ridenour, T., Lin, C.‐Y., Gorelick, J.
Publicado 2021

Ixekizumab improves secondary lesional signs, pain and sexual health in patients with moderate‐to‐severe genital psoriasis

por Merola, J.F., Ghislain, P.‐D., Dauendorffer, J.N., Potts Bleakman, A., Brnabic, A.J.M., Burge, R., Riedl, E.
Publicado 2020

Ixekizumab provides persistent improvements in health‐related quality of life and the sexual impact associated with moderate‐to‐severe genital psoriasis in adult patients during a...

por Ryan, C., Guenther, L., Foley, P., Weisman, J., Burge, R.T., Gallo, G., See, K., McKean‐Matthews, M., Bertram, C.C., Merola, J.F.
Publicado 2021

Association between teriparatide treatment persistence and adherence, and fracture incidence in Taiwan: analysis using the National Health Insurance Research Database

por Chan, D.-C., Chang, C. H.-C., Lim, L.-C., Brnabic, A. J. M., Tsauo, J.-Y., Burge, R., Hsiao, F.-Y., Jin, L., Gürbüz, S., Yang, R.-S.
Publicado 2016

Continuous dosing versus interrupted therapy with ixekizumab: an integrated analysis of two phase 3 trials in psoriasis

por Blauvelt, A., Papp, K.A., Sofen, H., Augustin, M., Yosipovitch, G., Katoh, N., Mrowietz, U., Ohtsuki, M., Poulin, Y., Shrom, D., Burge, R., See, K., Mallbris, L., Gordon, K.B.
Publicado 2017

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 12‐week efficacy, safety and speed of response from a randomized, doubl...

por Blauvelt, A., Papp, K., Gottlieb, A., Jarell, A., Reich, K., Maari, C., Gordon, K.B., Ferris, L.K., Langley, R.G., Tada, Y., Lima, R.G., Elmaraghy, H., Gallo, G., Renda, L., Park, S.Y., Burge, R., Bagel, J.
Publicado 2020

A head‐to‐head comparison of ixekizumab vs. guselkumab in patients with moderate‐to‐severe plaque psoriasis: 24‐week efficacy and safety results from a randomized, double‐blinded t...

por Blauvelt, A., Leonardi, C., Elewski, B., Crowley, J.J., Guenther, L.C., Gooderham, M., Langley, R.G., Vender, R., Pinter, A., Griffiths, C.E.M., Tada, Y., Elmaraghy, H., Lima, R.G., Gallo, G., Renda, L., Burge, R., Park, S.Y., Zhu, B., Papp, K.
Publicado 2020

The TRIUMF KAON factory, TRI-PP-85-36

por Craddock, M K, Baartman, R A, Beveridge, J L, Blackmore, E W, Botman, J I M, Burge, R S, Cameron, W, Doornbos, J, Hodges, T A, Lobb, D E, MacKenzie, G H, Oram, C J, Otter, Alan J, Raparia, D, Reeve, P A, Rihardson, J R, Stinson, G M, Thorson, I M, Worsham, R E, Lacey, W K, Planner, C W, Pedersen, F, Schönauer, Horst Otto, Suzuki, T, Yamaguchi, C
Publicado 1985